echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > PPAR-Alpha Cloning, Expression, and Characterization

    PPAR-Alpha Cloning, Expression, and Characterization

    • Last Update: 2020-12-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Peroxisome proliferator-activated receptor α (PPARα) is a member of the nuclear/steroid receptor gene superfamily that alsocomprises β, δ, and γ isoforms. PPARα is a ligand-activated transcription factor that plays an important role in the regulationof many genes involved in key metabolic processes. Today, PPARα has been cloned from mammalian, marsupial, and a number ofmarine species and its expression has been found to be relatively tissue- and species-specific. Here, we describe the methodsfor cloning of PPARα genes by RT-
    PCR
    and RACE approaches and related protocols for studying the expression of cloned PPARαc
    DNA
    s in mammalian cell systems.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.